Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model

Yoshikazu Tasaki(Asahikawa Medical College Hospital), Kazuo Matsubara(Wakayama Medical University)

Neuroscience Letters

May 22, 2012

10.1016/j.neulet.2012.05.045

Cited by 25

Related Papers

Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity

|European Journal of Pharmacology|2011|22

Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells

|PLoS ONE|2015|6